ADIPOQ and myeloid sarcoma: Accordingly, it appears that the hormonal and pathophysiological constellation in females with MS facilitates the augmenting effect of adiponectin on HDL bioavailability, exemplified by the observed positive associations between adiponectin and HDL, independently of the tested confounders.